11![achanA May 7, 2008 ® Mycamine Has Now Been Approved in Europe Japan, May 7, [removed]Astellas Pharma Inc. (headquarters: Tokyo, president and CEO: Masafumi Nogimori, achanA May 7, 2008 ® Mycamine Has Now Been Approved in Europe Japan, May 7, [removed]Astellas Pharma Inc. (headquarters: Tokyo, president and CEO: Masafumi Nogimori,](https://www.pdfsearch.io/img/ac10f1c90e05f18d882cffb37987f6f9.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2008-09-17 23:58:30
|
---|
12![apprCreated by Astellas PharmaApproved: Malcolm bn achanA August 1, 2008 ® apprCreated by Astellas PharmaApproved: Malcolm bn achanA August 1, 2008 ®](https://www.pdfsearch.io/img/89d3a7b320596c88443e8ff3d0686626.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2008-09-17 23:37:51
|
---|
13![4-7, Doshomachi 3-chome, Chuo-ku, Osaka[removed], Japan Telephone : [removed]Facsimile : [removed]URL http://www.fujisawa.co.jp/ E-mail : [removed] February 25, 2003 4-7, Doshomachi 3-chome, Chuo-ku, Osaka[removed], Japan Telephone : [removed]Facsimile : [removed]URL http://www.fujisawa.co.jp/ E-mail : [removed] February 25, 2003](https://www.pdfsearch.io/img/9de310fcebca747c9303856b7e66c47e.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2008-12-10 01:07:49
|
---|
14![Corporate Communications 4-7, Doshomachi 3-chome, Chuoku, Osaka[removed], Japan Telephone : [removed]Facsimile : [removed]URL http://www.fujisawa.co.jp/ E-mail : [removed] Corporate Communications 4-7, Doshomachi 3-chome, Chuoku, Osaka[removed], Japan Telephone : [removed]Facsimile : [removed]URL http://www.fujisawa.co.jp/ E-mail : [removed]](https://www.pdfsearch.io/img/d15cc0e05b79d77edbb1b40b39e59ef2.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2008-12-10 01:08:03
|
---|
15![Fujisawa Healthcare, Inc. Corporate Communications Three Parkway North Deerfield, Illinois[removed]Tel[removed]Telefax[removed]www.fujisawa.com Fujisawa Healthcare, Inc. Corporate Communications Three Parkway North Deerfield, Illinois[removed]Tel[removed]Telefax[removed]www.fujisawa.com](https://www.pdfsearch.io/img/36c8851a0669eb573f71f456bb1881a5.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2008-12-10 01:08:07
|
---|
16![4-7, Doshomachi 3-chome, Chuo-ku, Osaka[removed], Japan Telephone : [removed]Facsimile : [removed]URL http://www.fujisawa.co.jp/ E-mail : [removed] February 3, 2003 4-7, Doshomachi 3-chome, Chuo-ku, Osaka[removed], Japan Telephone : [removed]Facsimile : [removed]URL http://www.fujisawa.co.jp/ E-mail : [removed] February 3, 2003](https://www.pdfsearch.io/img/612a4917062b50c6c3a501dfb955b0c9.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2008-12-10 01:07:48
|
---|
17![Corporate Communications 4-7, Doshomachi 3-chome, Chuoku, Osaka[removed], Japan Telephone : [removed]Facsimile : [removed]URL http://www.fujisawa.co.jp/ E-mail : [removed] Corporate Communications 4-7, Doshomachi 3-chome, Chuoku, Osaka[removed], Japan Telephone : [removed]Facsimile : [removed]URL http://www.fujisawa.co.jp/ E-mail : [removed]](https://www.pdfsearch.io/img/a4a57375554f9afb39e5f47ccbae3c08.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2008-12-10 01:08:03
|
---|
18![Microsoft Word - Mycamine Pediatric_Press Release FINALv2.docx Microsoft Word - Mycamine Pediatric_Press Release FINALv2.docx](https://www.pdfsearch.io/img/7c2d6c8400e328e81de5b9114024c839.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2013-06-24 05:53:12
|
---|
19![MEDICINE REVIEW ARTICLE Yeasts in the Gut: From Commensals to Infectious Agents MEDICINE REVIEW ARTICLE Yeasts in the Gut: From Commensals to Infectious Agents](https://www.pdfsearch.io/img/d0a4e9c8468fe8e410bb121744f027ce.jpg) | Add to Reading ListSource URL: www.thecandidadiet.comLanguage: English - Date: 2013-04-26 12:58:29
|
---|
20![MODEL PRESS RELEASE Astellas Pharma US Inc. Pays $7.3 Million to Resolve False Claims Act Allegations Relating to Marketing of Drug Mycamine The National Association of Medicaid Fraud Control Units announced on July 11, MODEL PRESS RELEASE Astellas Pharma US Inc. Pays $7.3 Million to Resolve False Claims Act Allegations Relating to Marketing of Drug Mycamine The National Association of Medicaid Fraud Control Units announced on July 11,](https://www.pdfsearch.io/img/985aa60c4f9c3ceb329247e74c10731a.jpg) | Add to Reading ListSource URL: www.namfcu.netLanguage: English - Date: 2014-07-11 12:42:09
|
---|